(Q46565206)

23 December 2017

title

Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure (English)

1 reference

23 December 2017

1 reference

Vaziri ND

1

1 reference

23 December 2017

Liang K

series ordinal

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

23 December 2017

published in

Kidney International

1 reference

23 December 2017

volume

50

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

1928-1935

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.1996.515

exact match

0 references

cites work

Lipid abnormalities in uremia, dialysis, and transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Lipoprotein metabolism and renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Serum apolipoprotein profile of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Increased lipoprotein-remnant formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Adipose Tissue Lipoprotein Lipase in Chronic Hemodialysis: Role in Plasma Triglyceride Metabolism*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Impaired lipoprotein lipase activation by uraemic and post-transplant sera

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Lipoprotein heterogeneity in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Effects of erythropoietin therapy on the lipid profile in end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Preparation, characterization, and measurement of lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Impaired metabolism of high density lipoprotein in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Catabolism of low-density lipoprotein is altered in experimental chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Decreased clearance of low-density lipoprotein in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Severe defect in clearing postprandial chylomicron remnants in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Lipoprotein lipase: recent contributions from molecular biology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Factors of increase in serum triglyceride-rich lipoproteins in uremic rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1996.515

7 January 2021

Identifiers

DOI

10.1038/KI.1996.515

1 reference

23 December 2017

Dimensions Publication ID

1010612654

0 references

1 reference

23 December 2017